Pharma Spends 0.3% Of Sales On Post-Market Safety Activities, CERT Says
Executive Summary
Pharmaceutical companies spend an average 0.3% of sales on post-marketing safety studies, an unpublished Centers for Education & Research on Therapeutics report finds